Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

EMETE-CON

BENZQUINAMIDE HYDROCHLORIDE

Standard Dose
EQ 50MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview EMETE-CON is listed in Drugs@FDA under application 016820 (NDA).

Marketing status: Discontinued Active ingredient BENZQUINAMIDE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor PFIZER Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview EMETE-CON is listed in Drugs@FDA under application 016820 (NDA). Marketing status: Discontinued Active ingredient BENZQUINAMIDE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/VIAL Sponsor PFIZER Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
EMETE-CON (BENZQUINAMIDE HYDROCHLORIDE) | Drug Monograph | MedicHelpline